Dr. Syed Nadeem Ahmed

A Visionary Leader in the Pharma Industry

Dr. Syed Nadeem Ahmed, a distinguished professional with a stellar career spanning 32 years in the Pharmaceutical and Healthcare Industry, currently holds the prestigious positions of Group Managing Director of IBL and Chief Executive Officer of The Searle Company Limited. With a remarkable 15-year tenure at Searle, the largest and fastest-growing pharmaceuticals company in Pakistan, Dr. Nadeem has played a pivotal role in the organization’s success.

Dr. Syed Nadeem Ahmed

A Visionary Leader in the Pharma Industry

Dr. Syed Nadeem Ahmed, a distinguished professional with a stellar career spanning 32 years in the Pharmaceutical and Healthcare Industry, currently holds the prestigious positions of Group Managing Director of IBL and Chief Executive Officer of The Searle Company Limited. With a remarkable 15-year tenure at Searle, the largest and fastest-growing pharmaceuticals company in Pakistan, Dr. Nadeem has played a pivotal role in the organization’s success.

  • Group Managing Director, International Brand Ltd. IBL Group
  •  Chief Executive Officer, The Searle Company Ltd.
  • Director, IBL Healthcare Ltd.
  • Director, UDL Pakistan Ltd.
  • Director, United Brands Ltd.
  • Director, Dunkin Donuts
  • Executive Director, Habitt Home Store
  • Director, IKL (Pvt,) Ltd.
  • Director, Nextar Pharma (Pvt.) Ltd.
  • Director, FMC Private Ltd.
  • Ex. Director, Employer Federation of Pakistan
  •  Trustee, AKAR Charity Hospital, Karachi.
Years
of Pharmaceutical and Healthcare Industry
0
years
at Searle Group Limited
0
Plus
Awards and Honors
0
top
current positions
0

Education

Dr. Nadeem’s educational journey is equally impressive, holding a graduate degree in Mechanical Engineering, a Master’s degree in Management Engineering, and a Doctorate Degree in Business Administration. His pursuit of knowledge has taken him to renowned institutions worldwide, including The IET in London, Ateneo De Manila University in the Philippines, Harvard University in Boston, and the University of Oxford in England.

Academic Education & Professional Education

  • MIET in Mechanical Engineering, Institution of Engineering & Technology, London, UK • M.S in Management Engineering, from Adamson University, Manila, Philippines • Doctor of Business Administration, European University, Geneva, Switzerland
  • FCMI, Fellow of Chartered Management Institute, Royal Charter UK
  • FCIM, Fellow of Chartered Institute of Marketing, Berkshire, England
  • FCIML, Fellow of Chartered Institute of Management & Leadership, USA
  • FCILG, Fellow of Chartered Institute of Leadership & Governance, USA
  • BBEM, Harvard University, Boston, USA
  • Antibiotic Stewardship, Stanford University, USA
  • AMPP, University of Oxford, Oxford, UK
  • SDGs for 21st Century, Yonsei University, Seoul, Korea
  • Operational Planning & Guidelines Covid-19, WHO
  • OHM, Royal College of Orthopedic, Bangkok, Thailand
  • Management Supervising, Atenio De Manila University, Manila, Philippines
  • CDC, Institute of Chartered Accountant of Pakistan, Karachi, Pakistan

Achievements

Under his leadership, Searle has achieved notable recognition, being the only pharmaceutical company in Pakistan selected by Forbes among the best 200 companies in Asia. Dr. Nadeem’s extensive experience extends beyond Searle, as he serves as a Director in various prominent organizations, including IBL Health Care Limited, UDL Pakistan Limited, United Brands Limited, and many others.

Memberships

A distinguished member of the Pakistan Pharmaceutical Manufacturers Association (PPMA), Dr. Nadeem has garnered accolades throughout his career, receiving fellowships from esteemed organizations such as the Chartered Management Institute (CMI) in England and the Chartered Institute of Marketing in Berkshire, UK.

Awards

Dr. Nadeem’s commitment to excellence is evident in his extensive list of achievements, including his appointment as Brand Ambassador for the Wallonia Region, Belgium, and receiving the highest award of honor from Cyprus International University. He has also been recognized for his leadership, receiving the Leadership Award from EU Business School in Geneva, presented by former President of Switzerland, Mr. Adolf Ogi.

  • Orthopedic Conference Award, from Royal College of Orthopedic, Thailand handed over by the King HIS HIGNESS Bhumibol Adulyadej Bangkok, Thailand
  • Outstanding Research Recognition, from the president office Mrs. Qurazone Aquino, Manila, Philippines
  • Highest Award of Honor for Education, from Cyprus International University, handed over by the Mayor of Lefkosa Mr. Semi Bora. Lefkosa, Cyprus
  • Leadership Award, EU Business School, handed over by the president of Switzerland Mr. Adolf Ogi. Geneva, Switzerland
  • Enterprising Initiative Award, from the Business Council of Madrid Community, handed over by the Mayor of Madrid, Mr. Manuel Coba Vega. Madrid, Spain
  • Brand Ambassador of Wallonia region, Liege, Belgium
  • Foreign Investment Delegate Award, from Economic Development Board Mauritius, handed over by the President of Mauritius Dr. Ameenah Gurib Fakim. Port Louis, Mauritius
  • SDG, Sustainable Developments Goals Certificate, handed over by Mr. Ban Ki Moon former General Secretary United Nation, Geneva, Switzerland
  • Searle Best Performing Co. in Pakistan Stocks, received from MSCI, USA
  • Searle listed among the best Companies from Pakistan, in Financial Times Index, UK
  • Leading Pharmaceutical Co. Award, from the Government of Pakistan, handed over by the President of Pakistan Mr. Asif Ali Zardari. Islamabad, Pakistan
  • CEO Searle listed among the Top 100 CEOs of Pakistan, award handed over by General Zubair Mehmood Hayat Chairman Joint Chiefs of Staff Committee, Pakistan.
  • Searle recognized as best performing company under a billion US$, by Forbes Asia Singapore
  • Searle awarded as Most Outstanding Company in Pakistan by Asiamoney, Hong kong
  • Searle received Corporate Excellence & Sustainability Award, by ACES, Malaysia

Leadership

In response to the challenges posed by the Covid-19 pandemic, Dr. Nadeem participated in WHO’s operational planning program to support country preparedness. Recently elected as a Fellow of the Chartered Institute of Management & Leadership USA and the Chartered Institute of Leadership & Governance USA, Dr. Nadeem continues to contribute to the industry by delivering lectures and talks in leading business universities and institutions in Pakistan and abroad.

Dr. Syed Nadeem Ahmed stands as a beacon of leadership, innovation, and excellence in the pharmaceutical and healthcare sector, shaping the future of the industry with his unparalleled expertise and dedication.

Authored an Insightful Book on the Pharma Industry of Pakistan

Impact of the World’s Developed Pharmaceutical Industry’s Emerging Portfolios on the Pharmaceutical Industry of’ Pakistan: Analyses, Solutions and Recommendations for Long-Term Sustainability & Revolutionary Growth.

Image Slide 2
BOOK REVIEW

“The excellent book by Dr. Syed Nadeem Ahmed, CEO of Searle Pharmaceuticals, presents a comprehensive overview of the challenges and opportunities faced by the pharma industry of Pakistan. It highlights the importance of focusing on the new and emerging pharma products that will occupy a central place in the future, including biological and biosimilars. The need
for research and development in the new and emerging areas is emphasized. The book should serve as a valuable guide for the pharmaceutical industry, the government and the research community in respect of solutions to the present problems,
sustainability and robust growth.”

Prof. Atta-ur-Rahman, FRS, N.I., H.I., S.I., T.I.

UNESCO Science Laureate, Chairman PM’s National Task Force on Science and Technology Academician Chinese Academy of Sciences. Professor Emeritus International Centre for Chemical and Biological Sciences University of Karachi, Pakistan.

Image Slide 2
BOOK REVIEW

“This is a must in pharma strategy. An enlightening insight reading into the multifold future of the health industry. A pleasure to read.”

Prof. Stef de Jong

Dean, EU Business School Geneva-Switzerland

Image Slide 2
BOOK REVIEW

“A thought-provoking book in the context of the pharma industry from the lens of emerging portfolios. This is a must-read for business students, especially those aspiring to be a leader in the industry.”

Dr. Wajid H. Rizvi. Ph.D

Former Dean, School Business Studies IBA, Karachi-Pakistan

previous arrowprevious arrow
next arrownext arrow
Shadow

Spearheading The Searle Company Ltd

Founded in Omaha, Nebraska, in 1888 by Gideon Daniel Searle, and incorporated in Pakistan as a Private Limited Company in October 1965, The Searle Company Limited was acquired by International Brand Limited (IBL) in November 1993 and is now a part of IBL, commanding the leading position in many consumer categories.

The Searle Pakistan (Pvt) Limited has acquired the manufacturing facility in S.I.T.E. where production of Aldactone, Lomotil, Diodoquin, Ovulen, Neomycin Sulphate, Probanthine and Hydryllin was started.

Over the years the manufacturing operations expanded and the construction of a new plant started in 1984. In mid-1986 manufacturing operations of pharmaceutical products commenced at this newly built factory on Plot # F-319, S.I.T.E. Area, Karachi, measuring 5.24 acres. On November 14th, the company was converted into a Public Limited Company as The Searle Company Limited (TSCL).

In 2013, Searle acquired the state-of-the-art Biological Plant from Nextar in the Port Qasim Area of Karachi and filed for USFDA approval for the manufacture of Biosimilars. Over 5 years Searle has achieved extensive globalization and registered with regulatory authorities of many European and African Countries.